The Nigeria Center for Disease Control, NCDC, has responded to the British government declaration of a modest and generally accessible medication that spares patients genuinely sick with COVID-19.
Review that British Prime Minister on Tuesday said UK scientists recognized another medication, which is compelling and has diminished COVID-19 deaths chance.
The medication recognized as Dexamethasone has decreased death danger for patients in ventilators by 33% and oxygen by one fifth.
Responding, the NCDC in a tweet on its official Twitter handle, said the medication won’t be utilized to treat patients since it has not been endorsed by the World Health Organization, WHO.
SEE ALSO: New case record in Beijing, as WHO issues new warning
It said, “The NCDC is aware of recent outcomes from a UK-Government funded clinical trial for COVID-19.
“The results support the use of Dexamethsaone as a possible treatment to reduce the risk of death among COVID-19 patients, who require oxygen or mechanical ventilation.
“Please note that the Government of Nigeria has not validated or approved any treatment for COVID-19.
“In addition, the use of Dexamethasone for COVID-19 treatment has not been validated by @WHO.”
